These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 14652070)

  • 1. Structural basis for thrombin activation of a protease-activated receptor: inhibition of intramolecular liganding.
    Seeley S; Covic L; Jacques SL; Sudmeier J; Baleja JD; Kuliopulos A
    Chem Biol; 2003 Nov; 10(11):1033-41. PubMed ID: 14652070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Substrate-assisted catalysis of the PAR1 thrombin receptor. Enhancement of macromolecular association and cleavage.
    Jacques SL; LeMasurier M; Sheridan PJ; Seeley SK; Kuliopulos A
    J Biol Chem; 2000 Dec; 275(52):40671-8. PubMed ID: 11005807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protease-activated receptor-4 uses dual prolines and an anionic retention motif for thrombin recognition and cleavage.
    Jacques SL; Kuliopulos A
    Biochem J; 2003 Dec; 376(Pt 3):733-40. PubMed ID: 13678420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteolysis of the exodomain of recombinant protease-activated receptors: prediction of receptor activation or inactivation by MALDI mass spectrometry.
    Loew D; Perrault C; Morales M; Moog S; Ravanat C; Schuhler S; Arcone R; Pietropaolo C; Cazenave JP; van Dorsselaer A; Lanza F
    Biochemistry; 2000 Sep; 39(35):10812-22. PubMed ID: 10978167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombin receptor activation. Confirmation of the intramolecular tethered liganding hypothesis and discovery of an alternative intermolecular liganding mode.
    Chen J; Ishii M; Wang L; Ishii K; Coughlin SR
    J Biol Chem; 1994 Jun; 269(23):16041-5. PubMed ID: 8206902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasmin desensitization of the PAR1 thrombin receptor: kinetics, sites of truncation, and implications for thrombolytic therapy.
    Kuliopulos A; Covic L; Seeley SK; Sheridan PJ; Helin J; Costello CE
    Biochemistry; 1999 Apr; 38(14):4572-85. PubMed ID: 10194379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural basis of thrombin-protease-activated receptor interactions.
    Gandhi PS; Chen Z; Appelbaum E; Zapata F; Di Cera E
    IUBMB Life; 2011 Jun; 63(6):375-82. PubMed ID: 21698746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crystallographic structures of thrombin complexed with thrombin receptor peptides: existence of expected and novel binding modes.
    Mathews II; Padmanabhan KP; Ganesh V; Tulinsky A; Ishii M; Chen J; Turck CW; Coughlin SR; Fenton JW
    Biochemistry; 1994 Mar; 33(11):3266-79. PubMed ID: 8136362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protease-activated receptor-1 can mediate responses to SFLLRN in thrombin-desensitized cells: evidence for a novel mechanism for preventing or terminating signaling by PAR1's tethered ligand.
    Hammes SR; Coughlin SR
    Biochemistry; 1999 Feb; 38(8):2486-93. PubMed ID: 10029543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of thrombin with PAR1 and PAR4 at the thrombin cleavage site.
    Nieman MT; Schmaier AH
    Biochemistry; 2007 Jul; 46(29):8603-10. PubMed ID: 17595115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protease-activated receptor 4 uses anionic residues to interact with alpha-thrombin in the absence or presence of protease-activated receptor 1.
    Nieman MT
    Biochemistry; 2008 Dec; 47(50):13279-86. PubMed ID: 19053259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulated shedding of PAR1 N-terminal exodomain from endothelial cells.
    Ludeman MJ; Zheng YW; Ishii K; Coughlin SR
    J Biol Chem; 2004 Apr; 279(18):18592-9. PubMed ID: 14982936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crystal structure of thrombin bound to the uncleaved extracellular fragment of PAR1.
    Gandhi PS; Chen Z; Di Cera E
    J Biol Chem; 2010 May; 285(20):15393-15398. PubMed ID: 20236938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determinants of thrombin receptor cleavage. Receptor domains involved, specificity, and role of the P3 aspartate.
    Ishii K; Gerszten R; Zheng YW; Welsh JB; Turck CW; Coughlin SR
    J Biol Chem; 1995 Jul; 270(27):16435-40. PubMed ID: 7608215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteinase-activated receptors (PARs)--the PAR3 Neo-N-terminal peptide TFRGAP interacts with PAR1.
    Kaufmann R; Schulze B; Krause G; Mayr LM; Settmacher U; Henklein P
    Regul Pept; 2005 Feb; 125(1-3):61-6. PubMed ID: 15582715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cofactoring and dimerization of proteinase-activated receptors.
    Lin H; Liu AP; Smith TH; Trejo J
    Pharmacol Rev; 2013; 65(4):1198-213. PubMed ID: 24064459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Agonist recognition by proteinase-activated receptor 2 and thrombin receptor. Importance of extracellular loop interactions for receptor function.
    Lerner DJ; Chen M; Tram T; Coughlin SR
    J Biol Chem; 1996 Jun; 271(24):13943-7. PubMed ID: 8662993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A New Concept of Action of Hemostatic Proteases on Inflammation, Neurotoxicity, and Tissue Regeneration.
    Gorbacheva LR; Kiseleva EV; Savinkova IG; Strukova SM
    Biochemistry (Mosc); 2017 Jul; 82(7):778-790. PubMed ID: 28918742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombin and protease-activated receptors (PARs) in atherothrombosis.
    Martorell L; Martínez-González J; Rodríguez C; Gentile M; Calvayrac O; Badimon L
    Thromb Haemost; 2008 Feb; 99(2):305-15. PubMed ID: 18278179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-linked glycosylation of protease-activated receptor-1 second extracellular loop: a critical determinant for ligand-induced receptor activation and internalization.
    Soto AG; Trejo J
    J Biol Chem; 2010 Jun; 285(24):18781-93. PubMed ID: 20368337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.